- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05433714
Figure of 8 Walk Test in Multiple Sclerosis
The Reliability and Validity of the Figure of 8 Walk Test in Multiple Sclerosis
Study Overview
Detailed Description
Multiple sclerosis (MS) is a progressive disease of the central nervous system characterized by demyelination and destruction of motor and sensory axons. As the disease worsens, it is associated with impaired balance, difficulty walking, decreased mobility, and an increased risk of falling. The prevalence of balance dysfunction in individuals with MS and Given its clinical relevance, the assessment of balance has become an important focus in MS clinical practice and research. The figure of 8 Walk Test is a standard clinical measure used to evaluate the forward walking performance required in daily life.In the figure of 8 walk test, two cones are placed 1.5 meters apart. The individual stands in the middle of this distance. At the start of the test, he goes around the first cone as fast as he can walk around the first cone, then when he comes to the other starting point, this time around the other cone. The elapsed time is recorded.
The aim of the study is to examine the validity and reliability of the 8-shape walking test in MS patients.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Kahramanmaraş, Turkey
- Kahramanmaraş Sütçü İmam University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Having an EDSS score of 4 and below,
- Being between the ages of 18-65
- Willingness to participate in the study
Exclusion Criteria:
- Being pregnant or within the first 3 months after giving birth,
- Receiving corticosteroid therapy in the last 1 month,
- Using drugs that will affect walking in the last 1 month
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Multiple sclerosis patient
First day, first evaluator will perform all tests, and second day, second evaluator will perform the figure of 8 walk test.
|
The figure of walk test, Berg Balance scale, Timed 25-Foot Walk, Timed up and go test, Foursquare walk test
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Figure of Walk Test
Time Frame: First day
|
Two cones are placed 1.5 meters apart.
The individual stands in the middle of this distance.
At the start of the test, he goes around the first cone as fast as he can walk around the first cone, then when he comes to the other starting point, this time around the other cone.
Elapsed time is recorded
|
First day
|
|
The Figure of Walk Test
Time Frame: second day
|
Two cones are placed 1.5 meters apart.
The individual stands in the middle of this distance.
At the start of the test, he goes around the first cone as fast as he can walk around the first cone, then when he comes to the other starting point, this time around the other cone.
Elapsed time is recorded
|
second day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Berg Balance scale
Time Frame: First day
|
It is a 14-item scale that measures the ability to maintain balance while performing functional tasks.
Each item is scored between 0 and 4. Balance is considered good if the total score is 45 and above.
|
First day
|
|
Timed up and go test
Time Frame: First day
|
At the beginning of the test, individuals sit in a chair.
A distance of 3 m is set in front of it.
With the start command, he gets up from his seat and walks 3 m, turns around and walks back and sits.
With the start command, the time to sit on the chair is recorded in seconds.
Short duration indicates good functional mobility.
|
First day
|
|
Timed 25-Foot Walk test
Time Frame: First day
|
It is an evaluation to evaluate mobility and leg functions.
Individuals are asked to safely walk 7.62 m on a flat surface at their highest speed.
|
First day
|
|
Four Square Step Test
Time Frame: First day
|
It aims to assess dynamic balance and step objects forward, sideways and backwards.
The square drawn on the floor is divided into 4 equal parts.
The number 1 is written in the lower right corner, up to 4 clockwise.
With the start command, individuals are asked to step on the numbers in order.
|
First day
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ipekkrmc
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Assesment
-
University of SevilleActive, not recruiting
-
Gaziantep Islam Science and Technology UniversityNot yet recruiting
-
Cairo UniversityCompleted
-
Kahramanmaras Sutcu Imam UniversityWithdrawn
-
Harran UniversityCompletedSurgery--Complications | Arthropathy | Physical DisabilityTurkey
-
Pamukkale UniversityCompleted
-
Kutahya Health Sciences UniversityRecruiting
-
Acibadem UniversityCompletedAdolescent Idiopathic Scoliosis | Body SchemaTurkey (Türkiye)
-
Istanbul Kültür UniversityIstanbul University - CerrahpasaCompletedAdolescent | Flat Foot Acquired Bilateral (Pes Planus) | Foot Posture Index Score | Balance Assessment | Toe Flexor StrengthTurkey (Türkiye)
-
Sanko UniversityCompletedMultiple Sclerosis | Balance; Distorted | Walking, DifficultyTurkey